Stearylamine-based nanoemulsion : preparation, characterization and

physical stability investigation by Sirbubalo, Merima et al.
II. Symposium of Young Researchers on Pharmaceutical Technology, 
Biotechnology and Regulatory Science 




Stearylamine-based nanoemulsion: preparation, characterization and 
physical stability investigation 
Merima Sirbubalo1, Amina Tucak1, Edina Vranić1, Andreas Zimmer2 
1University of Sarajevo, Faculty of Pharmacy, Department of Pharmaceutical Technology 
2University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and 
Biopharmacy 
 
Oil-in-water cationic nanoemulsions (CNE) are fine dispersions consisting of an oil core (from 
natural or synthetic origin) stabilized by a single cationic lipid or a mixture with phospholipids, 
non-ionic surfactants, and/or PEG-lipids. CNEs are considered to be suitable and potential 
delivery system for nucleic acids in gene therapy field due to their positively charged surface 
which complex with negatively charged gene material through electrostatic interactions [1]. 
The aim of the present study was to evaluate the effect of cationic lipid-sterylamine (SA) on 
mean droplet size, zeta potential and pH of the CNEs. Formulations containing various 
concentrations of SA were prepared on high-pressure homogenizer. The mean droplet size 
and zeta potential of the emulsions were determined by photon correlation spectroscopy  and 
electrophoretic light scattering, respectively (Malvern NanoZs Zetasizer). The mean droplet 
size of emulsions varied from 126 to 129 nm while the polydispersity index varied from 0,068 
to 0,137. As expected, zeta-potential increased from +43,7 mV to +53,7 mV with the SA 
concentration increase from 0,25 to 0,75 % (w/w). During the 60-day storage period at 25 °C, 
the droplets stayed in the nanometer range with only a minor size increase (~10 nm), no 
significant changes in droplet size distribution nor zeta potential or any difference in their 
visual appearance (no creaming or phase separation) proving therefore a satisfactory 
formulation stability.   
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